Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems

Kitahata, Mari M.; Rodrı́guez, Benigno; Haubrich, Richard; Boswell, Stephen L.; Mathews, W. Christopher; Lederman, Michael M.; Lober, William B.; Rompaey, Stephen E. Van; Crane, Heidi M.; Moore, Richard D.; Bertram, Michael G.; Kahn, James O.; Saag, Michael S.

doi:10.1093/ije/dym231

Cited by 252 publications

(287 citation statements)

References 31 publications

Supporting

Mentioning

286

Contrasting

Unclassified

Order By: Relevance

“…Participants were a cross-sectional convenience sample from the Universities of Washington (UW) and Alabama at Birmingham (UAB) HIV clinics, both Centers for AIDS Research Network of Integrated Clinical Systems clinical sites [13] (Table 2). All participants were in routine clinical care and completed PRO assessments between August 2008 and December 2009.…”

Section: Methodsmentioning

confidence: 99%

Migrating from a legacy fixed-format measure to CAT administration: calibrating the PHQ-9 to the PROMIS depression measures

et al. 2011

View full text Add to dashboard Cite

Purpose We provide detailed instructions for analyzing patient-reported outcome (PRO) data collected with an existing (legacy) instrument so that scores can be calibrated to the PRO Measurement Information System (PROMIS) metric. This calibration facilitates migration to computerized adaptive test (CAT) PROMIS data collection, while facilitating research using historical legacy data alongside new PROMIS data. Methods A cross-sectional convenience sample (n = 2,178) from the Universities of Washington and Alabama at Birmingham HIV clinics completed the PROMIS short form and Patient Health Questionnaire (PHQ-9) depression symptom measures between August 2008 and December 2009. We calibrated the tests using item response theory. We compared measurement precision of the PHQ-9, the PROMIS short form, and simulated PROMIS CAT. Results Dimensionality analyses confirmed the PHQ-9 could be calibrated to the PROMIS metric. We provide code used to score the PHQ-9 on the PROMIS metric. The mean standard errors of measurement were 0.49 for the PHQ-9, 0.35 for the PROMIS short form, and 0.37, 0.28, and 0.27 for 3-, 8-, and 9-item-simulated CATs. Conclusions The strategy described here facilitated migration from a fixed-format legacy scale to PROMIS CAT administration and may be useful in other settings.

show abstract

Section: Methodsmentioning

confidence: 99%

Migrating from a legacy fixed-format measure to CAT administration: calibrating the PHQ-9 to the PROMIS depression measures

et al. 2011

View full text Add to dashboard Cite

show abstract

“…study 16 ) as well as other clinic-based cohorts (e.g., 10% annual drop out among participants in the Centers for AIDS Research Network of Integrated Clinical Systems 17 ). Compared to other clinic-based cohorts, 17 the UNC clinic cohort was older at enrollment with a greater proportion of females and African-Americans. Among participants retained in the cohort, the majority of the person-time was contributed while participants were on cART.…”

Section: Discussionmentioning

confidence: 99%

Enrollment, Retention, and Visit Attendance in the University of North Carolina Center for AIDS Research HIV Clinical Cohort, 2001–2007

Howe

Cole

Napravnik

et al. 2010

AIDS Research and Human Retroviruses

View full text Add to dashboard Cite

Predictors of study retention and scheduled visit attendance in the University of North Carolina Center for AIDS Research (UNC CFAR) prospective clinical cohort of HIV-infected patients enrolled between 1 January 2001 and 1 January 2008 are reported. At study entry, 1636 participants were 32% female, 58% were African-American, 49% had not received HIV care elsewhere, 71% were receiving or initiated combination antiretroviral therapy, and 26% were diagnosed with AIDS, with median (quartiles) age of 40 (34; 47) years, distance to clinic of 45 (21; 70) miles, HIV-1 RNA of 1396 (200; 26,750) copies/ml, and CD4 of 374 (182; 602) cells/mm 3 . Participants contributed a median of 7 (4; 13) scheduled visits and 2.25 (1.0; 3.9) years alive under follow-up. During 6134 person-years of follow-up, 414 participants dropped out and 145 died. Accounting for differences in death by participant characteristics, the 6-year cumulative probability of retention was 67% [95% confidence limits (CL): 65, 70%], with 6.75 (95% CL: 6.13, 7.43) drop outs per 100 person-years. In a multivariable Cox proportional hazards model, retention was higher among participants who were insured, had not received HIV care elsewhere, had controlled HIV viremia, and were living in nonurban areas or proximate to the clinic. In a multivariable modified Poisson regression model that accounted for differences in drop out and death by participant characteristics, visit attendance was higher among older, AIDS-diagnosed, immune compromised, and cARTinitiated participants. The UNC CFAR clinical cohort has ample enrollment with retention and visit attendance modestly influenced by factors such as disease severity.

show abstract

“…Patient geography and demography (i.e., age, gender, race/ethnicity, sexual identity) predict both substance use among HIV care enrollees (50–52) and SUD rates in community sampling (53, 54), and therby merit inclusion in such analytic work. The Center for AIDS Research Network of Integrated Clinical Systems (CNICS) (55) is a U.S.-based data source offering a multi-regional, continuous cohort of HIV care enrollees, with demographic information and capacity to delineate substance-specific SUDs.…”

Section: Introductionmentioning

confidence: 99%

Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States

et al. 2016

View full text Add to dashboard Cite

Prior efforts to estimate U.S. prevalence of substance use disorders (SUDs) in HIV care have been undermined by caveats common to single-site trials. The current work reports on a cohort of 10,652 HIV-positive adults linked to care at seven sites, with available patient data including geography, demography, and risk factor indices, and with substance-specific SUDs identified via self-report instruments with validated diagnostic thresholds. Generalized estimating equations also tested patient indices as SUD predictors. Findings were: 1) a 48% SUD prevalence rate (between-site range of 21–71%), with 20% of the sample evidencing polysubstance use disorder; 2) substance-specific SUD rates of 31% for marijuana, 19% alcohol, 13% methamphetamine, 11% cocaine, and 4% opiate; and 3) emergence of younger age and male gender as robust SUD predictors. Findings suggest high rates at which SUDs occur among patients at these urban HIV care sites, detail substance-specific SUD rates, and identify at-risk patient subgroups.

show abstract

Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems

Cited by 252 publications

References 31 publications

Migrating from a legacy fixed-format measure to CAT administration: calibrating the PHQ-9 to the PROMIS depression measures

Migrating from a legacy fixed-format measure to CAT administration: calibrating the PHQ-9 to the PROMIS depression measures

Enrollment, Retention, and Visit Attendance in the University of North Carolina Center for AIDS Research HIV Clinical Cohort, 2001–2007

Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States

Contact Info

Product

Resources

About